Concepedia

Monica M. Bertagnolli

MM

148

Publications

23.6K

Citations

71

H-Index

1990

Active since

Affiliations

Brigham and Women's Hospital(Current)

Dana-Farber Cancer Institute

Harvard University

Memorial Sloan Kettering Cancer Center

Dana-Farber Brigham Cancer Center

Monica M. Bertagnolli is an author at Brigham and Women's Hospital specializing in medicine, cancer research, and pathology.

ORCID

Top concepts

Publications per year

1990–2025

148

Publications

148

Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq

Itay Tirosh, Benjamin Izar, Sanjay M. Prakadan et al. · Science · 2016 · 5K citations · Full text

, , +19

Cardiovascular Risk Associated with Celecoxib in a Clinical Trial for Colorectal Adenoma Prevention

Scott D. Solomon, John J.V. McMurray, Marc A. Pfeffer et al. · New England Journal of Medicine · 2005 · 2K citations · Full text

Celecoxib for the Prevention of Sporadic Colorectal Adenomas

Monica M. Bertagnolli, Craig Eagle, Ann G. Zauber et al. · New England Journal of Medicine · 2006 · 1K citations · Full text

Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With <i>KRAS</i> Wild-Type Advanced or Metastatic Colorectal Cancer

Alan P. Venook, Donna Niedzwiecki, Heinz‐Josef Lenz et al. · JAMA · 2017 · 852 citations · Full text

Correlation of Kinase Genotype and Clinical Outcome in the North American Intergroup Phase III Trial of Imatinib Mesylate for Treatment of Advanced Gastrointestinal Stromal Tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group

Michael C. Heinrich, Kouros Owzar, Christopher L. Corless et al. · Journal of Clinical Oncology · 2008 · 649 citations · Full text

Rows per page

1–5 of 148